论文部分内容阅读
Mesothelioma is a notoriously chemotherapy-resistant neoplasm, as is evident in the dismal overall survival for patients with this asbestos-associated disease.We previously demonstrated co-activation of multiple receptor tyrosine kinases (RTK), including EGFR, MET, and AXL in mesothelioma cell lines,suggesting that these kinases could serve as novel therapeutic targets.